MCP-1 mediates TGF-β-induced angiogenesis by stimulating vascular smooth muscle cell migration

被引:176
作者
Ma, Jing
Wang, Qiang
Fei, Teng
Han, Jing-Dong Jackie
Chen, Ye-Guang [1 ]
机构
[1] Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China
[2] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China
关键词
D O I
10.1182/blood-2006-07-036400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transforming growth factor-beta (TGF-beta) and its signaling mediators play crucial roles in vascular formation. Our previous microarray analysis identified monocyte chemoattractant protein-1 (MCP-1) as a TGF-beta target gene in endothelial cells (ECs). Here, we report that MCP-1 mediates the angiogenic effect of TGF-beta by recruiting vascular smooth muscle cells (VSMCs) and mesenchymal cells toward ECs. By using a chick chorioallantoic membrane assay, we show that TGF-beta promotes the formation of new blood vessels and this promotion is attenuated when MCP-1 activity is blocked by its neutralizing antibody. Wound healing and transwell assays established that MCPA functions as a chemoattractant to stimulate migration of VSMCs and mesenchymal 10T1/2 cells toward ECs. Furthermore, the conditioned media from TGF-beta-treated ECs stimulate VSMC migration, and inhibition of MCPA activity attenuates TGF-beta-induced VSMC migration toward ECs. Finally, we found that MCP-1 is a direct gene target of TGF-beta via Smad3/4. Taken together, our findings suggest that MCP-1 mediates TGF-beta-stimulated angiogenesis by enhancing migration of mural cells toward ECs and thus promoting the maturation of new blood vessels.
引用
收藏
页码:987 / 994
页数:8
相关论文
共 50 条
[1]   Endothelial/pericyte interactions [J].
Armulik, A ;
Abramsson, A ;
Betsholtz, C .
CIRCULATION RESEARCH, 2005, 97 (06) :512-523
[2]   Transforming growth factor beta in cardiovascular development and function [J].
Azhar, M ;
Schultz, JEJ ;
Grupp, I ;
Dorn, GW ;
Meneton, P ;
Molin, DGM ;
Gittenberger-de Groot, AC ;
Doetschman, T .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (05) :391-407
[3]   Insight into the physiological functions of PDGF through genetic studies in mice [J].
Betsholtz, C .
CYTOKINE & GROWTH FACTOR REVIEWS, 2004, 15 (04) :215-228
[4]   Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities [J].
Bjarnegård, M ;
Enge, M ;
Norlin, J ;
Gustafsdottir, S ;
Fredriksson, S ;
Abramsson, A ;
Takemoto, M ;
Gustafsson, E ;
Fässler, R ;
Betsholtz, C .
DEVELOPMENT, 2004, 131 (08) :1847-1857
[5]   INDIRECT ANGIOGENIC CYTOKINES UP-REGULATE VEGF AND BFGF GENE-EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS, WHEREAS HYPOXIA UP-REGULATES VEGF EXPRESSION ONLY [J].
BROGI, E ;
WU, TG ;
NAMIKI, A ;
ISNER, JM .
CIRCULATION, 1994, 90 (02) :649-652
[6]   Angiogenesis in life, disease and medicine [J].
Carmeliet, P .
NATURE, 2005, 438 (7070) :932-936
[7]   Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis [J].
Caunt, M ;
Hu, L ;
Tang, T ;
Brooks, PC ;
Ibrahim, S ;
Karpatkin, S .
CANCER RESEARCH, 2006, 66 (08) :4125-4132
[8]   Chemokines in the pathogenesis of vascular disease [J].
Charo, IF ;
Taubman, MB .
CIRCULATION RESEARCH, 2004, 95 (09) :858-866
[9]   Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[10]  
DICKSON MC, 1995, DEVELOPMENT, V121, P1845